MNPs have the capacity to cross the BBB and are covalently attached to antisense oligonucleotides to target glioblastoma cells by suppressing EGFR/EGFRvIII and c-Myc nuclear transcription factors. This evidence concerns the gene EGFR and glioblastoma.